Aubagio

Teriflunomide

6.9 High risk

Aubagio & Multiple sclerosis relapse

5.3%

of users reported Multiple sclerosis relapse

94.6%

also reported Severe reaction

79.3%

are women

Most common medical consequences

Severe reaction
94.6%
Hospitalization
4.7%
Disability
0.3%
Death
0.1%
Life-threatening condition
0.1%
Birth Defects
0.1%

Have you experienced any negative side effects from this medication?

Aubagio: general information

Most common side effects (388)

Most commonly affected ages

10 - 19 years
<0.1%
20 - 29 years
2.8%
30 - 39 years
11.3%
40 - 49 years
23.9%
50 - 59 years
34.3%
60 - 69 years
22.4%
70 - 79 years
5.1%
80 - 89 years
0.3%